Cargando…

Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering

The discovery of bioactive glasses (BGs) in the late 1960s by Larry Hench et al. was driven by the need for implant materials with an ability to bond to living tissues, which were intended to replace inert metal and plastic implants that were not well tolerated by the body. Among a number of tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Hugo R., Gaddam, Anuraag, Rebelo, Avito, Brazete, Daniela, Stan, George E., Ferreira, José M. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316906/
https://www.ncbi.nlm.nih.gov/pubmed/30545136
http://dx.doi.org/10.3390/ma11122530
_version_ 1783384640204046336
author Fernandes, Hugo R.
Gaddam, Anuraag
Rebelo, Avito
Brazete, Daniela
Stan, George E.
Ferreira, José M. F.
author_facet Fernandes, Hugo R.
Gaddam, Anuraag
Rebelo, Avito
Brazete, Daniela
Stan, George E.
Ferreira, José M. F.
author_sort Fernandes, Hugo R.
collection PubMed
description The discovery of bioactive glasses (BGs) in the late 1960s by Larry Hench et al. was driven by the need for implant materials with an ability to bond to living tissues, which were intended to replace inert metal and plastic implants that were not well tolerated by the body. Among a number of tested compositions, the one that later became designated by the well-known trademark of 45S5 Bioglass(®) excelled in its ability to bond to bone and soft tissues. Bonding to living tissues was mediated through the formation of an interfacial bone-like hydroxyapatite layer when the bioglass was put in contact with biological fluids in vivo. This feature represented a remarkable milestone, and has inspired many other investigations aiming at further exploring the in vitro and in vivo performances of this and other related BG compositions. This paradigmatic example of a target-oriented research is certainly one of the most valuable contributions that one can learn from Larry Hench. Such a goal-oriented approach needs to be continuously stimulated, aiming at finding out better performing materials to overcome the limitations of the existing ones, including the 45S5 Bioglass(®). Its well-known that its main limitations include: (i) the high pH environment that is created by its high sodium content could turn it cytotoxic; (ii) and the poor sintering ability makes the fabrication of porous three-dimensional (3D) scaffolds difficult. All of these relevant features strongly depend on a number of interrelated factors that need to be well compromised. The selected chemical composition strongly determines the glass structure, the biocompatibility, the degradation rate, and the ease of processing (scaffolds fabrication and sintering). This manuscript presents a first general appraisal of the scientific output in the interrelated areas of bioactive glasses and glass-ceramics, scaffolds, implant coatings, and tissue engineering. Then, it gives an overview of the critical issues that need to be considered when developing bioactive glasses for healthcare applications. The aim is to provide knowledge-based tools towards guiding young researchers in the design of new bioactive glass compositions, taking into account the desired functional properties.
format Online
Article
Text
id pubmed-6316906
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63169062019-01-08 Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering Fernandes, Hugo R. Gaddam, Anuraag Rebelo, Avito Brazete, Daniela Stan, George E. Ferreira, José M. F. Materials (Basel) Review The discovery of bioactive glasses (BGs) in the late 1960s by Larry Hench et al. was driven by the need for implant materials with an ability to bond to living tissues, which were intended to replace inert metal and plastic implants that were not well tolerated by the body. Among a number of tested compositions, the one that later became designated by the well-known trademark of 45S5 Bioglass(®) excelled in its ability to bond to bone and soft tissues. Bonding to living tissues was mediated through the formation of an interfacial bone-like hydroxyapatite layer when the bioglass was put in contact with biological fluids in vivo. This feature represented a remarkable milestone, and has inspired many other investigations aiming at further exploring the in vitro and in vivo performances of this and other related BG compositions. This paradigmatic example of a target-oriented research is certainly one of the most valuable contributions that one can learn from Larry Hench. Such a goal-oriented approach needs to be continuously stimulated, aiming at finding out better performing materials to overcome the limitations of the existing ones, including the 45S5 Bioglass(®). Its well-known that its main limitations include: (i) the high pH environment that is created by its high sodium content could turn it cytotoxic; (ii) and the poor sintering ability makes the fabrication of porous three-dimensional (3D) scaffolds difficult. All of these relevant features strongly depend on a number of interrelated factors that need to be well compromised. The selected chemical composition strongly determines the glass structure, the biocompatibility, the degradation rate, and the ease of processing (scaffolds fabrication and sintering). This manuscript presents a first general appraisal of the scientific output in the interrelated areas of bioactive glasses and glass-ceramics, scaffolds, implant coatings, and tissue engineering. Then, it gives an overview of the critical issues that need to be considered when developing bioactive glasses for healthcare applications. The aim is to provide knowledge-based tools towards guiding young researchers in the design of new bioactive glass compositions, taking into account the desired functional properties. MDPI 2018-12-12 /pmc/articles/PMC6316906/ /pubmed/30545136 http://dx.doi.org/10.3390/ma11122530 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fernandes, Hugo R.
Gaddam, Anuraag
Rebelo, Avito
Brazete, Daniela
Stan, George E.
Ferreira, José M. F.
Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title_full Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title_fullStr Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title_full_unstemmed Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title_short Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering
title_sort bioactive glasses and glass-ceramics for healthcare applications in bone regeneration and tissue engineering
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316906/
https://www.ncbi.nlm.nih.gov/pubmed/30545136
http://dx.doi.org/10.3390/ma11122530
work_keys_str_mv AT fernandeshugor bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering
AT gaddamanuraag bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering
AT rebeloavito bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering
AT brazetedaniela bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering
AT stangeorgee bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering
AT ferreirajosemf bioactiveglassesandglassceramicsforhealthcareapplicationsinboneregenerationandtissueengineering